TEAR Company Financials

TEAR 
$9.92
*  
0.24
  negative  
2.36%
Get TEAR Alerts
*Delayed - data as of May 20, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    TEAR After Hours
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time


Annual Income Statement (values in 000's)

Period Ending: Trend 12/31/2012 12/31/2011 12/31/2010 12/31/2009
Total Revenue
$3,960 $2,124 $1,701 $869
Cost of Revenue
$2,295 $1,626 $849 $568
Gross Profit
$1,665 $498 $852 $301
Operating Expenses
Research and Development
$2,241 $1,304 $1,365 $1,121
Sales, General and Admin.
$10,241 $6,037 $5,216 $3,891
Non-Recurring Items
$0 $0 $0 $0
Other Operating Items
$1,215 $1,215 $1,215 $1,215
Operating Income
($12,032) ($8,058) ($6,944) ($5,926)
Add'l income/expense items
($7,280) ($656) $471 ($269)
Earnings Before Interest and Tax
($19,312) ($8,714) ($6,473) ($6,195)
Interest Expense
$0 $95 $210 $93
Earnings Before Tax
($19,312) ($8,809) ($6,683) ($6,288)
Income Tax
$0 $0 $0 ($1,903)
Minority Interest
$0 $0 $0 $0
Equity Earnings/Loss Unconsolidated Subsidiary
$0 $0 $0 $0
Net Income-Cont. Operations
($19,312) ($8,809) ($6,683) ($4,385)
Net Income
($19,312) ($8,809) ($6,683) ($4,385)
Net Income Applicable to Common Shareholders
($19,312) ($8,809) ($6,683) ($4,385)

See also: Company Financials data entry page